NCT00515086 - Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

Glioblastoma Multiforme

Interventions

DRUG

Everolimus

Tablets taken once a day with a full glass of water.

PROCEDURE

Surgery

Salvage surgical resection

Trial Locations (8)

Duke University - Preston Robert Tisch Brain Tumor Center, Durham

University of Cincinnati, Cincinnati

Northwestern University, Chicago

UCLA, Los Angeles

Seattle Cancer Care Alliance, Seattle

Massachusetts General Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Dana Farber Cancer Institute, Boston